Ondansetron Stada

Ondansetron, the active ingredient in Ondansetron Stada, is a serotonin 5-HT3 receptor antagonist presented as a tablet for oral use. It is used to prevent nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery in adults and children. GNH USA supplies Ondansetron Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Ondansetron Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ondansetron is used to manage nausea and vomiting by acting on the central nervous system pathways that trigger these symptoms.

- Chemotherapy‑induced nausea and vomiting: helps prevent and control acute and delayed episodes. - Radiation‑induced nausea and vomiting: reduces the frequency and severity of symptoms. - Post‑operative nausea and vomiting: decreases the incidence of nausea after surgery. - Hyper‑emesis gravidarum (off‑label): may be considered when standard therapies fail, under specialist specialist specialist specialist specialist specialist specialist specialist specialist specialist  ...